Key Takeaways
- RKLB shares surged 46% during the first six months of 2026, significantly outpacing the S&P 500’s 10% advance
- First quarter 2026 revenue reached an all-time high of $200 million, representing 63% year-over-year growth and exceeding Wall Street’s $189.65 million forecast
- Contract backlog more than doubled year-over-year to $2.2 billion, with the company securing 70 missions for future launches
- Institutional investors control 71.78% of outstanding shares, with several prominent hedge funds expanding their stakes during Q1
- Analyst consensus remains overwhelmingly positive, with 81% issuing buy or strong buy recommendations and price targets averaging between $111 and $117
Rocket Lab (RKLB) shares are currently changing hands at approximately $78.32, representing a decline from the 52-week peak of $151.00 but maintaining a substantial premium over the 52-week floor of $37.57. The aerospace company’s stock delivered a 46% return during the first half of 2026, substantially outperforming the broader S&P 500 index, which advanced just 10% during the identical timeframe.
The Long Beach-based space launch provider has delivered consecutive record-breaking quarters throughout 2026. During Q4 2025, the company generated $180 million in revenue, marking a 36% increase from the prior-year period. The momentum accelerated into Q1 2026, with revenue climbing to $200.35 million ā representing a robust 63.4% year-over-year expansion and surpassing the Street’s $189.65 million projection.
The company reported a loss of ($0.07) per share, which aligned precisely with analyst forecasts. This represents an improvement from the ($0.12) per-share loss recorded in the comparable quarter of 2025.
Contract Pipeline and Mission Success Rate Signal Robust Demand
The company’s contract backlog serves as perhaps the most compelling indicator of future business trajectory. Total backlog reached $2.2 billion in Q1, representing a 106% year-over-year increase and a 20% sequential gain from Q4 2025. The launch manifest now includes 70 contracted missions awaiting execution.
Company leadership disclosed that Rocket Lab secured more launch contracts during the first quarter alone than throughout the entirety of 2025. This acceleration in bookings represents a significant inflection point. The organization also maintained a perfect 100% mission success rate across 21 orbital launches executed last year.
Looking ahead to Q2 2026, executives have provided guidance calling for approximately $233 million in revenue at the midpoint ā implying roughly 61% growth compared to the year-ago quarter.
The company’s pending $8 billion Iridium acquisition factors prominently into the strategic narrative, with management positioning Rocket Lab as a comprehensive “end-to-end space company” offering integrated solutions.
Hedge Funds and Institutions Continue Accumulating Shares
Institutional investors maintain commanding ownership of RKLB stock, controlling 71.78% of all outstanding shares. Multiple prominent investment firms expanded their positions during the first quarter. AQR Capital Management more than doubled its holdings with a 114% increase, now owning 174,308 shares. NewEdge Advisors dramatically increased its stake by over 1,800%. Katamaran Capital boosted its position by 86.2%.
Among the 16 sell-side analysts tracking the stock, 81% maintain buy or strong buy ratings. Notably, zero analysts recommend selling shares. Price targets span from a conservative $111.88 to New Street Research’s bullish $150 projection. Citizens JMP elevated its target to $130 on June 30, while KeyCorp upgraded shares to overweight with a $135 objective in June.
The insider selling activity presents a contrasting narrative. CEO Peter Beck divested 1,298,622 shares on July 7 at an average execution price of $84.92, generating proceeds exceeding $110 million. This transaction was conducted pursuant to a predetermined Rule 10b5-1 trading arrangement. Company insiders have collectively sold approximately $362.8 million in stock over the trailing three-month period.
From a technical perspective, Rocket Lab’s 50-day moving average stands at $109.12, while the 200-day moving average registers at $87.32 ā both residing above the current trading price of $78.32.


